Latest Breaking News On - Mike mcmullen - Page 8 : comparemela.com

Davis High skiers sweep divisions

Davis High skiers sweep divisions
davisenterprise.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from davisenterprise.com Daily Mail and Mail on Sunday newspapers.

United statesNick mandelarisBryce harveyMike mcmullenDavid luCharlie mellemaMadeline luKatie mcmullenReese wattersonBevan wallaceLily schroederRielly gallesOlivia sanchiricoAuburn ski club at boreal onNevada unionSnowboard federation

Yeti (YETI) Q4 2023 Earnings Call Transcript

YETI earnings call for the period ending December 31, 2023.

United statesRed seaDjibouti generalNew yorkBrooke roach goldman sachsBrooke roachBrian mcnamara canaccord genuityPeter benedictJim duffyMegan alexander morgan stanleyAmerica merrill lynchMatt reintjesCanaccord genuityPeter keith piper sandlerNoah zatzkinLayne rigney

Mystery Ranch part of two Yeti deals totaling about $48 5M

Yeti Holdings paid about $48.5 million for both Mystery Ranch and a Maryland-based cookware manufacturer, company executives said Thursday.

United statesSouth dakotaLayne rigneyMike mcmullenMatt reintjesYeti holdingsButter pat industriesMystery ranchOsprey packsDana designOutdoor retailerNorth americaHe economy

Yeti (YETI) Q4 2023 Earnings Call Transcript

YETI earnings call for the period ending December 31, 2023.

New yorkUnited statesRed seaDjibouti generalJim duffyPiper sandlerBrooke roachBrian mcnamaraPeter keithBrian mcnamara canaccord genuityPeter keith piper sandlerNoah zatzkin keybancNoah zatzkinPeter benedictLayne rigneyBrooke roach goldman sachs

Agilent, Incyte ink companion diagnostics deal

Agilent, Incyte ink companion diagnostics deal
fiercebiotech.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fiercebiotech.com Daily Mail and Mail on Sunday newspapers.

Merck keytrudaPaul beresfordBristol myers squibb opdivoMike mcmullenAgilent technologiesBig pharmaBristol myers squibb